1. Home
  2. GROW vs RVPH Comparison

GROW vs RVPH Comparison

Compare GROW & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • RVPH
  • Stock Information
  • Founded
  • GROW 1968
  • RVPH 2006
  • Country
  • GROW United States
  • RVPH United States
  • Employees
  • GROW N/A
  • RVPH N/A
  • Industry
  • GROW Investment Managers
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • RVPH Health Care
  • Exchange
  • GROW Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • GROW 37.5M
  • RVPH 36.4M
  • IPO Year
  • GROW N/A
  • RVPH N/A
  • Fundamental
  • Price
  • GROW $2.64
  • RVPH $1.26
  • Analyst Decision
  • GROW
  • RVPH Strong Buy
  • Analyst Count
  • GROW 0
  • RVPH 3
  • Target Price
  • GROW N/A
  • RVPH $14.33
  • AVG Volume (30 Days)
  • GROW 40.6K
  • RVPH 290.0K
  • Earning Date
  • GROW 05-09-2024
  • RVPH 08-12-2024
  • Dividend Yield
  • GROW 3.37%
  • RVPH N/A
  • EPS Growth
  • GROW 100.00
  • RVPH N/A
  • EPS
  • GROW 0.12
  • RVPH N/A
  • Revenue
  • GROW $11,854,000.00
  • RVPH N/A
  • Revenue This Year
  • GROW N/A
  • RVPH N/A
  • Revenue Next Year
  • GROW N/A
  • RVPH N/A
  • P/E Ratio
  • GROW $22.25
  • RVPH N/A
  • Revenue Growth
  • GROW N/A
  • RVPH N/A
  • 52 Week Low
  • GROW $2.47
  • RVPH $0.95
  • 52 Week High
  • GROW $3.26
  • RVPH $6.80
  • Technical
  • Relative Strength Index (RSI)
  • GROW 50.53
  • RVPH 50.66
  • Support Level
  • GROW $2.55
  • RVPH $0.95
  • Resistance Level
  • GROW $2.73
  • RVPH $1.30
  • Average True Range (ATR)
  • GROW 0.06
  • RVPH 0.14
  • MACD
  • GROW 0.00
  • RVPH 0.02
  • Stochastic Oscillator
  • GROW 47.22
  • RVPH 77.50

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company furnishes an investment program for each of the clients it manages and determines, subject to overall supervision by the applicable board of trustees of the clients, the clients investments pursuant to an advisory agreement. US Global manages the following business segments: Investment management services; Investment management services; and Corporate Investments. It derives all its revenue from Investment management services.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: